Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergan Buys Bonti, Releases New Data In Defense Of 'Iconic' Botox Brand

Executive Summary

Allergan declared that no other brand is more 'iconic' than Botox, during its medical aesthetics investor event, but the company also revealed several defensive moves to protect the neurotoxin's status, including the acquisition of fast-acting, short duration toxin maker Bonti.

Advertisement

Related Content

Deal Watch: Cigna Acquisition Of Express Scripts OKed By US Justice Dept.
Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend
Revance's Long-Acting RT002 Will Have Slow-Moving Impact On Allergan
Venture Funding Deals: Cell Medica Raises $73.2m, Tango Dances In With $55m

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel